Narcobarbital
From Wikipedia, the free encyclopedia
Narcobarbital
|
|
Systematic (IUPAC) name | |
5-(2-bromoprop-2-enyl)-1-methyl-5-propan-2-yl-1,3-diazinane-2,4,6-trione | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C11H15BrN2O3 |
Mol. mass | 303.152 g/mol |
Synonyms | Narcobarbital, Pronarcon |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Narcobarbital (Pronarcon) is a barbiturate derivative invented in the 1960s. It is an N-methylated derivative of Propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.
[edit] References
|